Cite
MLA Citation
I Krznaric et al.. “Similar long‐term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV‐1‐infected patients in a retrospective, real‐life cohort of 14 years.” HIV medicine, vol. 19, no. 9, 2018, pp. 662–667. http://access.bl.uk/ark:/81055/vdc_100066972742.0x000021